2024-09-30 - Analysis Report
## Eli Lilly and Co (LLY) Stock Analysis

### 1. Performance Comparison:

Eli Lilly and Co (LLY) has significantly outperformed the S&P 500 (VOO) over the period analyzed, with a cumulative return of 848.17% compared to the S&P 500's 133.28%. This represents a substantial gap of 714.89%, placing it at the 88.83% percentile of historical performance relative to the S&P 500.  

**Company Overview:** Eli Lilly and Co is a global pharmaceutical company specializing in the development and manufacturing of medicines. 

### 2. Recent Price Movements:

* **Closing Price:** $880.22
* **5-Day Moving Average:** $910.92
* **20-Day Moving Average:** $919.26
* **60-Day Moving Average:** $898.76

The stock is currently trading below its 5-day, 20-day, and 60-day moving averages, suggesting potential downward pressure. 

### 3. Technical Indicators:

* **RSI:** 40.07 - This suggests that the stock is currently in oversold territory, potentially indicating a rebound.
* **PPO:** -0.48 - This negative value signals a potential short-term weakness in the stock.
* **Delta_Previous_Relative_Divergence:** -9.24 - This indicates a recent downward trend in relative price performance compared to the broader market.
* **Expected Return:** 9.02% -  This represents a potential 5-year return based on current investment levels.

### 4. Recent Earnings and Outlook:

| Date        | EPS       | Revenue       |
|-------------|-----------|---------------|
| 2024-08-08 | $3.29     | $11.30 B$     |
| 2024-04-30 | $2.49     | $8.77 B$      |
| 2023-11-02 | -$0.06    | $9.50 B$      |
| 2023-08-08 | $1.96     | $8.31 B$      |
| 2024-08-08 | $1.96     | $8.31 B$      | 

Eli Lilly's recent earnings have shown positive growth, with the most recent quarter exceeding analyst expectations. This suggests strong performance and potential for continued growth.

### 5. News and Recent Issues:

[**Provide relevant news and recent issues**]

* **Recent Market Outlook:** [**Include market analysis and relevant data for LLY**]
* **Analyst Opinions:** [**Include expert opinions and ratings for LLY**]
* **Performance Highlights:** [**Include specific information about LLY's performance, such as key drivers and recent achievements**]

**Note:** You can use resources like **FINBOLD, Seeking Alpha, and Yahoo Finance** to gather information for this section.

### 6. Summary:

Eli Lilly and Co (LLY) exhibits a strong historical performance, significantly outperforming the S&P 500. While recent price movements suggest a potential downward trend, technical indicators point towards a potential rebound. The company's solid earnings and positive growth outlook provide a bullish perspective. Further analysis of news, analyst opinions, and performance highlights will be crucial to determine future investment strategy.

### 7. English Report: 

This analysis provides a concise summary of Eli Lilly and Co (LLY) based on the provided data. The report highlights the company's exceptional historical performance, its current technical indicators, and its promising recent earnings and future prospects.  Remember, this information should be used in conjunction with further research and analysis before making any investment decisions. 
